Loading...
XKRX
096760
Market cap174mUSD
Dec 05, Last price  
3,685.00KRW
1D
0.41%
1Q
9.19%
Jan 2017
-58.50%
IPO
5.98%
Name

JW Holdings Corp

Chart & Performance

D1W1MN
XKRX:096760 chart
P/E
4.11
P/S
0.29
EPS
895.75
Div Yield, %
Shrs. gr., 5y
-0.62%
Rev. gr., 5y
4.09%
Revenues
887.71b
-4.35%
237,690,310,000529,239,679,000556,675,690,000554,239,674,230516,012,168,270511,945,579,900530,262,876,270573,920,210,970622,617,304,970680,479,987,980683,718,165,770725,365,869,060726,423,996,270781,514,840,000788,936,980,900864,536,430,720928,071,670,920887,710,032,000
Net income
62.62b
+229.11%
-7,232,724,000-5,165,882,0001,040,783,000-11,563,027,000-32,112,262,000-22,032,155,92017,817,457,410-8,987,986,000181,412,000-8,663,432,00054,021,815,78023,169,194,370-31,636,720,3803,385,179,0004,434,634,09046,482,142,07019,026,282,33062,617,686,000
CFO
97.89b
-12.84%
16,241,967,0008,284,997,000-6,940,143,000-1,615,130,760-3,887,889,710861,853,070-54,030,353,410-17,175,940,050-23,975,359,150-29,214,390,35010,511,742,250195,762,386,11098,682,527,140108,622,768,000109,644,020,380104,426,313,770112,317,545,77097,892,442,000
Dividend
Dec 27, 2023105 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.
IPO date
Jul 31, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT